Uncategorized - October 10, 2018
Improving the development of biopharmaceuticals in Finland
Researchers of organic chemistry and biotechnology from the University of Turku are creating new medical technologies in an Ecosystem coordinated by Orion Corporation. Together with selected university research groups and other companies, Orion Corporation has assembled a New Modalities Ecosystem supported by funding from Business Finland. One goal of the Ecosystem is to improve the […]
Uncategorized - October 10, 2018
New results about immunotherapy in hereditary melanoma
Researchers at Karolinska Institutet have examined how effective immunological checkpoint therapy is for individuals with inherited CDKN2A mutation and metastatic melanoma. In recent years, new immunological treatments have appeared that many melanoma patients respond well to. These, so called immune checkpoint inhibitors treat cancer by inhibiting brake mechanisms in the immune system, a discovery by […]
Uncategorized - September 12, 2018
Discovery of new neurons in the inner ear
Researchers at Karolinska Institutet have identified four types of neurons in the peripheral auditory system, three of which are new to science, they report Previously, most of the ear’s nerve cells were considered to be of two types: type 1 and type 2 neurons, type 1 transmitting most of the auditory information. The new study […]
Uncategorized - September 6, 2018
New genetic marker could help diagnose prostate cancer
Scientists from the University of Turku have discovered a link between certain genetic mutations, the aggressiveness of prostate cancer, risk of developing the disease and poorer survival rates of patients. The gene, called ANO7, could play a vital role in improving diagnosis of prostate cancer patients, reports the university. Genetic mutations, such as those revealed […]
Uncategorized - September 4, 2018
Mechanism behind multiple sclerosis risk identified
Researchers at Karolinska Institutet have discovered a new mechanism of a major risk gene for multiple sclerosis (MS) that triggers disease through so-called epigenetic regulation. Already over 40 years ago it was discovered that genetic variation in the so-called HLA region is the strongest risk factor for developing disease. HLA encodes molecules that are involved […]
Uncategorized - August 31, 2018
Lorelei Lingard is awarded the Karolinska Institutet Prize for Research in Medical Education
Professor Lorelei Lingard’s research has contributed significantly to our understanding of how healthcare professionals interact and communicate with each other, which has led to new clinical practices and increased patient safety. Professor Lingard, Professor in the Department of Medicine at the Schulich School of Medicine & Dentistry and cross-appointed in the Faculty of Education at […]